Sen. Mitt Romney, R-Utah, said March 31 that Republicans had reached an “agreement in principle” with Democrats on the $10 billion package, according to CNN. Senate Majority Leader Chuck Schumer, D-N.Y., said key senators are close to a deal that would garner bipartisan support.
Republican senators pitched the $10 billion package March 30, scaling back a $15.6 billion deal that was previously negotiated, according to Politico. About half of the $10 billion would be spent on therapeutic medicines to treat COVID-19. The Biden administration could use the remaining funds for a variety of initiatives, including researching long COVID-19, Politico reported March 31.
Lawmakers are under pressure from the Biden administration to pass additional funding. Without new funding, the administration is scaling back the distribution of monoclonal antibody treatments to states, and a program to pay for COVID-19 treatments and tests for the uninsured is out of funds.
Mr. Romney said the goal is to pass the bill next week, according to CNN.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.